We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA TO RE-EVALUATE DR. REDDY'S GENERIC NORVASC PRODUCT
FDA TO RE-EVALUATE DR. REDDY'S GENERIC NORVASC PRODUCT
February 10, 2004
Dr. Reddy’s new drug application (NDA) for a generic version of Pfizer’s hypertension and angina drug Norvasc will undergo additional scrutiny from the FDA because of questions regarding the source of the clinical trial data submitted by Dr. Reddy’s.